Connection

Athimalaipet Ramanan to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Athimalaipet Ramanan has written about Antibodies, Monoclonal.
Athimalaipet Ramanan
Connection Strength
0.048
Antibodies, Monoclonal
  1. Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials. Ann Rheum Dis. 2018 12; 77(12):1710-1719.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.